• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地尔硫䓬的血流动力学和电生理效应。

Haemodynamic and electrophysiologic effects of diltiazem.

作者信息

Bourassa M G

出版信息

Acta Pharmacol Toxicol (Copenh). 1985;57 Suppl 2:21-30. doi: 10.1111/j.1600-0773.1985.tb03571.x.

DOI:10.1111/j.1600-0773.1985.tb03571.x
PMID:4061103
Abstract

This review describes the haemodynamic and electrophysiologic properties of diltiazem and shows how these effects may, in some clinical situations, favour the choice of this drug as an antianginal and antiarrhythmic agent. Compared to nifedipine and verapamil, diltiazem has the distinct advantage of being a negative chronotropic agent and thus has the potential of leading to a greater reduction in myocardial oxygen consumption; it does not affect cardiac output, left ventricular end diastolic pressure, and ejection fraction in patients with an adequately preserved left ventricular function; finally, it possesses a longer duration of action and fewer side effects, even at relatively high calcium entry blocking doses, than the other major calcium entry blockers.

摘要

本综述描述了地尔硫䓬的血流动力学和电生理特性,并展示了在某些临床情况下,这些效应如何有利于将该药物选作抗心绞痛和抗心律失常药物。与硝苯地平和维拉帕米相比,地尔硫䓬具有明显的负性变时作用优势,因此有可能更大程度地降低心肌耗氧量;在左心室功能充分保留的患者中,它不影响心输出量、左心室舒张末期压力和射血分数;最后,与其他主要的钙通道阻滞剂相比,即使在相对高的钙通道阻滞剂量下,它也具有更长的作用持续时间和更少的副作用。

相似文献

1
Haemodynamic and electrophysiologic effects of diltiazem.地尔硫䓬的血流动力学和电生理效应。
Acta Pharmacol Toxicol (Copenh). 1985;57 Suppl 2:21-30. doi: 10.1111/j.1600-0773.1985.tb03571.x.
2
Electrophysiologic effects of diltiazem in canine myocardium, with special reference to conduction delay during ischemia.地尔硫䓬对犬心肌的电生理效应,特别提及缺血期间的传导延迟。
Am J Cardiol. 1982 Feb 18;49(3):602-5. doi: 10.1016/s0002-9149(82)80018-0.
3
Comparative effects of verapamil, diltiazem, and nifedipine on hemodynamics and left ventricular function during acute myocardial ischemia in dogs.维拉帕米、地尔硫䓬和硝苯地平对犬急性心肌缺血时血流动力学及左心室功能的比较作用
Circulation. 1984 Feb;69(2):382-90. doi: 10.1161/01.cir.69.2.382.
4
The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.硝苯地平、维拉帕米和地尔硫䓬对冠心病患者的血流动力学影响。综述。
Drugs. 1986 Jul;32(1):66-101. doi: 10.2165/00003495-198632010-00004.
5
Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue.地尔硫䓬、尼索地平与维拉帕米对心肌组织的电生理及冠状动脉血流动力学影响的比较
Am J Cardiol. 1982 Feb 18;49(3):613-20. doi: 10.1016/s0002-9149(82)80020-9.
6
Diltiazem. A review of its pharmacological properties and therapeutic efficacy.地尔硫䓬。其药理特性与治疗效果综述。
Drugs. 1985 May;29(5):387-454. doi: 10.2165/00003495-198529050-00001.
7
Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans.地尔硫䓬给药后麻醉犬和人体的血流动力学及冠状动脉血流情况。
Chest. 1980 Jul;78(1 Suppl):224-30. doi: 10.1378/chest.78.1_supplement.224.
8
Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.钙通道阻滞剂的不同心血管效应:潜在机制
Am J Cardiol. 1982 Feb 18;49(3):499-506. doi: 10.1016/s0002-9149(82)80002-7.
9
Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.苄普地尔、地尔硫䓬、硝苯地平和维拉帕米对麻醉犬血流动力学参数及心肌氧耗的比较作用
Arch Int Pharmacodyn Ther. 1986 Dec;284(2):276-96.
10
Effects of short-term intravenous administration of diltiazem on left ventricular function and coronary hemodynamics in patients with coronary artery disease.
J Cardiovasc Pharmacol. 1985 Nov-Dec;7(6):1138-48. doi: 10.1097/00005344-198511000-00020.

引用本文的文献

1
Pharmacokinetics and metabolism of diltiazem in healthy males and females following a single oral dose.
Eur J Drug Metab Pharmacokinet. 1993 Apr-Jun;18(2):199-206. doi: 10.1007/BF03188796.
2
Pharmacokinetics and metabolism of diltiazem in rats following a single intra-arterial or single oral dose.大鼠单次动脉内给药或单次口服给药后地尔硫䓬的药代动力学和代谢情况。
Eur J Drug Metab Pharmacokinet. 1994 Oct-Dec;19(4):369-73. doi: 10.1007/BF03188864.
3
Prolongation of the PQ interval as a measure of therapeutic inequivalence between two formulations of diltiazem.作为两种地尔硫䓬制剂治疗等效性衡量指标的PQ间期延长。
Eur J Clin Pharmacol. 1995;48(1):45-9. doi: 10.1007/BF00202171.